Skip to main content
. 2019 Jul 26;9:10847. doi: 10.1038/s41598-019-47347-6

Table 2.

Antibody response to FliC and association with SGG Gallo2178 and Gallo2179 antibody positivity.

FliC quartile Gallo2178 p-valueb Gallo2179 p-valueb
neg n (%) pos n (%) neg n (%) pos n (%)
Nijmegen/Detroit studies
Total 150 (100) 17 (100) 151 (100) 16 (100)
    Q1 36 (24) 2 (12) 35 (23) 3 (19)
    Q2 27 (18) 2 (12) 28 (19) 1 (6)
    Q3 29 (19) 8 (47) 29 (19) 8 (50)
    Q4 58 (39) 5 (29) 0.072 59 (39) 4 (25) 0.040
Controls 65 (100) 9 (100) 66 (100) 8 (100)
    Q1 17 (26) 2 (22) 16 (24) 3 (38)
    Q2 18 (28) 1 (11) 18 (27) 1 (13)
    Q3 14 (22) 3 (33) 14 (21) 3 (38)
    Q4 16 (25) 3 (33) 0.658 18 (27) 1 (13) 0.471
Cases a 85 (100) 8 (100) 85 (100) 8 (100)
    Q1 19 (22) 0 (0) 19 (22) 0 (0)
    Q2 9 (11) 1 (13) 10 (12) 0 (0)
    Q3 15 (18) 5 (63) 15 (18) 5 (63)
    Q4 42 (49) 2 (25) 0.023 41 (48) 3 (37) 0.021
MCC-Spain
Total 1012 (100) 140 (100) 1015 (100) 137 (100)
    Q1 268 (26) 28 (20) 269 (27) 27 (20)
    Q2 226 (22) 28 (20) 225 (22) 29 (21)
    Q3 247 (24) 41 (29) 250 (25) 38 (28)
    Q4 271 (27) 43 (31) 0.242 271 (27) 43 (31) 0.300
Controls 519 (100) 57 (100) 520 (100) 56 (100)
    Q1 130 (25) 15 (26) 135 (26) 10 (18)
    Q2 126 (24) 17 (30) 127 (24) 16 (29)
    Q3 132 (25) 12 (21) 126 (24) 18 (32)
    Q4 131 (25) 13 (23) 0.757 132 (25) 12 (21) 0.354
Cases a 493 (100) 83 (100) 495 (100) 81 (100)
    Q1 138 (28) 13 (16) 134 (27) 17 (21)
    Q2 100 (20) 11 (13) 98 (20) 13 (16)
    Q3 115 (23) 29 (35) 124 (25) 20 (25)
    Q4 140 (28) 30 (36) 0.011 139 (28) 31 (38) 0.268

aCases include n = 23 adenoma and n = 70 CRC cases for Nijmegen/Detroit studies, all cases were CRC in MCC Spain; bChi-Square test; significant associations (p-value < 0.05) are marked in bold font.